Sarepta names Ingram CEO

Sarepta Therapeutics Inc. (NASDAQ:SRPT) named Douglas Ingram president and CEO. He will succeed Edward Kaye, who had been planning to step down (see BioCentury Extra, April 27).

Ingram was president and CEO of Chase Pharmaceuticals Corp., which Allergan plc (NYSE:AGN) acquired (see BioCentury Extra, Nov. 22, 2016)...